Long-Term Renoprotective Effects of Losartan in Diabetic Nephropathy

Abstract

In contrast to previous observational studies with ACE inhibitors, long-term treatment with losartan has similar beneficial renoprotective effects on progression of diabetic nephropathy in hypertensive type 1 diabetic patients with ACE II and DD genotypes.